What is W.R Berkley's earnings per share (EPS)?

W.R Berkley (WRB) reported diluted earnings per share of $4.45 for fiscal year 2025. This represents a 2.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

W.R Berkley Financials

WRB

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows W.R Berkley (WRB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

4/9

W.R Berkley passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.01x

For every $1 of reported earnings, W.R Berkley generates $2.01 in operating cash flow ($3.6B OCF vs $1.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$14.7B

YoY+7.8%

5Y CAGR+12.7%

10Y CAGR+7.4%

W.R Berkley generated $14.7B in revenue in fiscal year 2025. This represents an increase of 7.8% from the prior year.

EBITDA

N/A

Net Income

$1.8B

YoY+1.3%

5Y CAGR+27.4%

10Y CAGR+13.5%

W.R Berkley reported $1.8B in net income in fiscal year 2025. This represents an increase of 1.3% from the prior year.

EPS (Diluted)

$4.45

YoY+2.1%

5Y CAGR+18.9%

10Y CAGR+1.4%

W.R Berkley earned $4.45 per diluted share (EPS) in fiscal year 2025. This represents an increase of 2.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$2.5B

YoY+28.6%

5Y CAGR+1.4%

10Y CAGR+12.8%

W.R Berkley held $2.5B in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.85

YoY+32.1%

5Y CAGR+42.9%

W.R Berkley paid $1.85 per share in dividends in fiscal year 2025. This represents an increase of 32.1% from the prior year.

Shares Outstanding

377M

YoY-0.5%

5Y CAGR+16.3%

10Y CAGR+11.8%

W.R Berkley had 377M shares outstanding in fiscal year 2025. This represents a decrease of 0.5% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

12.1%

YoY-0.8pp

5Y CAGR+5.5pp

10Y CAGR+5.1pp

W.R Berkley's net profit margin was 12.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.8 percentage points from the prior year.

Return on Equity

18.3%

YoY-2.6pp

5Y CAGR+9.9pp

10Y CAGR+7.4pp

W.R Berkley's ROE was 18.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$270.2M

YoY-11.0%

5Y CAGR-4.8%

10Y CAGR+1.9%

W.R Berkley spent $270.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 11.0% from the prior year.

Capital Expenditures

N/A

WRB Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$14.7B+7.8%	$13.6B+12.3%	$12.1B+8.7%	$11.2B+18.1%	$9.5B+16.7%	$8.1B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$126.9M0.0%	$126.9M-0.4%	$127.5M-2.2%	$130.4M-11.4%	$147.2M-2.2%	$150.5M
Income Tax	$495.8M-2.8%	$509.9M+37.6%	$370.6M+10.7%	$334.7M+32.9%	$251.9M+46.6%	$171.8M
Net Income	$1.8B+1.3%	$1.8B+27.1%	$1.4B0.0%	$1.4B+35.1%	$1.0B+92.7%	$530.7M
EPS (Diluted)	$4.45+2.1%	$4.36+29.4%	$3.37+2.4%	$3.29-10.1%	$3.66+95.7%	$1.87

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$3.7B-1.2%	$3.8B+2.7%	$3.7B+3.5%	$3.5B-3.3%	$3.7B+7.9%	$3.4B+2.6%	$3.3B+1.8%	$3.3B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$31.6M-0.4%	$31.8M-0.1%	$31.8M+0.2%	$31.7M-0.1%	$31.8M+0.1%	$31.7M0.0%	$31.7M-0.1%	$31.7M
Income Tax	$117.2M-13.9%	$136.1M+12.4%	$121.2M-0.1%	$121.3M-20.7%	$153.0M+40.2%	$109.1M-5.7%	$115.8M-12.3%	$132.0M
Net Income	$449.5M-12.0%	$511.0M+27.3%	$401.3M-3.9%	$417.6M-27.5%	$576.1M+57.6%	$365.6M-1.7%	$371.9M-15.9%	$442.5M
EPS (Diluted)	N/A	$1.28+28.0%	$1.00-3.8%	$1.04	N/A	$0.91-1.1%	$0.92-15.6%	$1.09

WRB Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$44.1B+8.6%	$40.6B+9.0%	$37.2B+9.9%	$33.9B+5.5%	$32.1B+12.2%	$28.6B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$2.5B+28.6%	$2.0B+44.9%	$1.4B-5.9%	$1.4B-7.6%	$1.6B-33.9%	$2.4B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$184.3M0.0%	$184.3M+5.6%	$174.6M-5.9%	$185.5M+9.3%	$169.7M0.0%	$169.7M
Total Liabilities	$34.4B+6.8%	$32.2B+8.2%	$29.7B+9.7%	$27.1B+6.6%	$25.4B+14.1%	$22.3B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$9.7B+15.6%	$8.4B+12.6%	$7.5B+10.5%	$6.7B+1.4%	$6.7B+5.4%	$6.3B
Retained Earnings	$13.3B+8.8%	$12.3B+11.1%	$11.0B+8.7%	$10.2B+12.7%	$9.0B+8.0%	$8.3B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$44.1B+0.8%	$43.7B+2.5%	$42.7B+3.2%	$41.3B+1.9%	$40.6B+0.5%	$40.4B+3.7%	$38.9B+2.8%	$37.9B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$2.5B+5.7%	$2.4B+21.1%	$2.0B+15.4%	$1.7B-12.9%	$2.0B+25.5%	$1.6B-0.4%	$1.6B+35.2%	$1.2B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$184.3M0.0%	$184.3M0.0%	$184.3M0.0%	$184.3M0.0%	$184.3M+0.1%	$184.1M0.0%	$184.1M+5.4%	$174.6M
Total Liabilities	$34.4B+1.3%	$33.9B+1.7%	$33.4B+2.9%	$32.4B+0.8%	$32.2B+0.8%	$31.9B+2.6%	$31.1B+3.6%	$30.1B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$9.7B-1.0%	$9.8B+5.4%	$9.3B+4.3%	$8.9B+6.2%	$8.4B-0.4%	$8.4B+8.4%	$7.8B-0.1%	$7.8B
Retained Earnings	$13.3B+0.3%	$13.3B+3.7%	$12.8B+1.4%	$12.7B+3.2%	$12.3B+3.0%	$11.9B+2.1%	$11.7B+1.9%	$11.5B

WRB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$3.6B-2.6%	$3.7B+25.6%	$2.9B+14.0%	$2.6B+17.6%	$2.2B+35.1%	$1.6B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$2.0B+7.1%	-$2.2B-11.3%	-$2.0B-3.7%	-$1.9B+36.7%	-$3.0B-2597.3%	$119.7M
Financing Cash Flow	-$1.0B-20.4%	-$852.5M+19.8%	-$1.1B-37.6%	-$772.0M-13339.4%	$5.8M+101.5%	-$397.8M
Dividends Paid	$700.3M+31.6%	$532.0M+6.1%	$501.5M+113.2%	$235.2M-33.9%	$355.7M+322.8%	$84.1M
Share Buybacks	$270.2M-11.0%	$303.7M-43.5%	$537.2M+470.6%	$94.1M-23.1%	$122.4M-64.7%	$346.4M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$995.1M-12.7%	$1.1B+62.0%	$703.8M-5.4%	$743.8M-8.2%	$810.0M-34.7%	$1.2B+40.8%	$881.3M+18.1%	$746.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$243.1M+61.3%	-$627.6M-168.0%	-$234.2M+74.7%	-$924.4M-961.8%	-$87.1M+92.1%	-$1.1B-1167.4%	-$87.2M+90.4%	-$905.1M
Financing Cash Flow	-$618.1M-548.8%	-$95.3M+58.9%	-$231.7M-184.6%	-$81.4M+72.0%	-$290.5M-88.9%	-$153.8M+59.4%	-$378.4M-1173.9%	-$29.7M
Dividends Paid	$411.9M+1104.7%	$34.2M-84.7%	$223.8M+637.8%	$30.3M-86.2%	$220.4M+75.2%	$125.8M-20.1%	$157.5M+458.1%	$28.2M
Share Buybacks	$196.4M+697.5%	$24.6M	$0-100.0%	$49.2M-27.0%	$67.4M+440.2%	$12.5M-94.4%	$223.8M	$0

WRB Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	12.1%-0.8pp	12.9%+1.5pp	11.4%-1.0pp	12.4%+1.6pp	10.8%+4.3pp	6.6%
Return on Equity	18.3%-2.6pp	20.9%+2.4pp	18.5%-1.9pp	20.5%+5.1pp	15.4%+7.0pp	8.4%
Return on Assets	4.0%-0.3pp	4.3%+0.6pp	3.7%-0.4pp	4.1%+0.9pp	3.2%+1.3pp	1.9%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	3.54-0.3	3.83-0.2	3.99-0.0	4.01+0.2	3.82+0.3	3.53
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	12.1%-1.5pp	13.6%+2.6pp	10.9%-0.8pp	11.8%-3.9pp	15.7%+5.0pp	10.8%-0.5pp	11.2%-2.4pp	13.6%
Return on Equity	4.6%-0.6pp	5.2%+0.9pp	4.3%-0.4pp	4.7%-2.2pp	6.9%+2.5pp	4.3%-0.4pp	4.8%-0.9pp	5.7%
Return on Assets	1.0%-0.1pp	1.2%+0.2pp	0.9%-0.1pp	1.0%-0.4pp	1.4%+0.5pp	0.9%-0.0pp	1.0%-0.2pp	1.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	3.54+0.1	3.46-0.1	3.59-0.0	3.64-0.2	3.83+0.0	3.79-0.2	4.00+0.1	3.86
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Markel Corporation MKL

$24.1B

Cincinnati Finl Corp CINF

$24.5B

The Hartford Insurance Group Inc HIG

$37.3B

Loews L

$22.0B

Allstate Corp ALL

$53.8B

Frequently Asked Questions

What is W.R Berkley's annual revenue?

W.R Berkley (WRB) reported $14.7B in total revenue for fiscal year 2025. This represents a 7.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is W.R Berkley's revenue growing?

W.R Berkley (WRB) revenue grew by 7.8% year-over-year, from $13.6B to $14.7B in fiscal year 2025.

Is W.R Berkley profitable?

Yes, W.R Berkley (WRB) reported a net income of $1.8B in fiscal year 2025, with a net profit margin of 12.1%.

What is W.R Berkley's net profit margin?

W.R Berkley (WRB) had a net profit margin of 12.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does W.R Berkley pay dividends?

Yes, W.R Berkley (WRB) paid $1.85 per share in dividends during fiscal year 2025.

What is W.R Berkley's return on equity (ROE)?

W.R Berkley (WRB) has a return on equity of 18.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is W.R Berkley's operating cash flow?

W.R Berkley (WRB) generated $3.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are W.R Berkley's total assets?

W.R Berkley (WRB) had $44.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Does W.R Berkley buy back shares?

Yes, W.R Berkley (WRB) spent $270.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does W.R Berkley have outstanding?

W.R Berkley (WRB) had 377M shares outstanding as of fiscal year 2025.

What is W.R Berkley's debt-to-equity ratio?

W.R Berkley (WRB) had a debt-to-equity ratio of 3.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is W.R Berkley's return on assets (ROA)?

W.R Berkley (WRB) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is W.R Berkley's Piotroski F-Score?

W.R Berkley (WRB) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are W.R Berkley's earnings high quality?

W.R Berkley (WRB) has an earnings quality ratio of 2.01x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.